NCT06874140View on ClinicalTrials.gov

Proteomic Study of Chuanhong Zhongfeng Capsule in the Treatment of ACI

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

January 1, 2025

Study Completion Date

January 1, 2025

Conditions
Acute Ischemic Stroke
Interventions
DRUG

Chuanhong Zhongfeng capsule

Basic treatment (refer to China Acute Ischemic Stroke Diagnosis and Treatment Guidelines 2018) + Chuanhong Zhongfeng capsule

Trial Locations (1)

Unknown

Changchun

All Listed Sponsors
lead

Yingyue Ding

OTHER

NCT06874140 - Proteomic Study of Chuanhong Zhongfeng Capsule in the Treatment of ACI | Biotech Hunter | Biotech Hunter